These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results. Pridöhl O; Heinemann K; Hartwig T; Witzigmann H; Lamesch P; Fangmann J; Berr F; Hauss J; Kohlhaw K Transplant Proc; 2001; 33(7-8):3229-31. PubMed ID: 11750384 [No Abstract] [Full Text] [Related]
4. Timing of conversion to mammalian target of rapamycin inhibitors is crucial in liver transplant recipients with impaired renal function at transplantation. Schleicher C; Palmes D; Utech M; Bonrath E; Senninger N; Schmidt H; Wolters H Transplant Proc; 2010 Sep; 42(7):2572-5. PubMed ID: 20832546 [TBL] [Abstract][Full Text] [Related]
5. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency. Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147 [TBL] [Abstract][Full Text] [Related]
6. Sirolimus conversion after liver transplantation: improvement in measured glomerular filtration rate after 2 years. Sanchez EQ; Martin AP; Ikegami T; Uemura T; Narasimhan G; Goldstein RM; Levy MF; Chinnakotla S; Dawson S; Randall HB; Saracino G; Klintmalm GB Transplant Proc; 2005 Dec; 37(10):4416-23. PubMed ID: 16387135 [TBL] [Abstract][Full Text] [Related]
7. Use of calcineurin inhibitors in pediatric liver transplantation: a single-center experience. Taylor RM; Cheeseman P; Rela M; Heaton N; Mieli-Vergani G; Dhawan A Transplant Proc; 2002 Aug; 34(5):1974-5. PubMed ID: 12176652 [No Abstract] [Full Text] [Related]
11. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. Chang GJ; Mahanty HD; Quan D; Freise CE; Ascher NL; Roberts JP; Stock PG; Hirose R Liver Transpl; 2000 Nov; 6(6):734-40. PubMed ID: 11084060 [TBL] [Abstract][Full Text] [Related]
13. [Consensus-recommendations for sirolimus in liver transplantation]. Golling M; Becker T; Broelsch C; Candinas D; Faust D; Fischer L; Geissler E; Graeb C; Iberer F; Klupp J; Kraus T; Müller AR; Neuhaus P; Strassburg CP; Wolff M; Zülke C; Bechstein WO Z Gastroenterol; 2004 Nov; 42(11):1333-40. PubMed ID: 15558447 [TBL] [Abstract][Full Text] [Related]
14. Sirolimus as rescue therapy after liver transplantation. Reigada CH; de Ataide EC; de Araújo FR; Ramos AP; Stucchi RS; Eescanhoela CA; Boin IF Transplant Proc; 2012 Oct; 44(8):2434-7. PubMed ID: 23026613 [TBL] [Abstract][Full Text] [Related]
15. Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants. Sindhi R; Ganjoo J; McGhee W; Mazariegos G; Reyes J Transplant Proc; 2002 Aug; 34(5):1972-3. PubMed ID: 12176651 [No Abstract] [Full Text] [Related]
16. Liver transplantation across ABO blood groups. Lang M; Neumann UP; Steinmüller T; Neuhaus P Transplant Proc; 2002 Aug; 34(5):1501-2. PubMed ID: 12176457 [No Abstract] [Full Text] [Related]
17. Conversion to sirolimus after kidney and liver transplantation: indications and outcomes. Wramner L; Norden G; Herlenius G; Friman S; Olausson M; Bäckman L Transplant Proc; 2003 Mar; 35(2):791. PubMed ID: 12644139 [No Abstract] [Full Text] [Related]
18. Immunosuppression and modulation in liver transplantation. Encke J; Uhl W; Stremmel W; Sauer P Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv22-5. PubMed ID: 15240845 [TBL] [Abstract][Full Text] [Related]
19. Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience. Wiseman AC; Kam I; Christians U; Jani A; Bak T; Wachs M; Chan L Transplant Proc; 2003 May; 35(3 Suppl):122S-124S. PubMed ID: 12742482 [No Abstract] [Full Text] [Related]
20. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]